Kynurenine pathway in kidney diseases
Izabela Zakrocka(Medical University of Lublin), Wojciech Załuska(Medical University of Lublin)
Cited by 53
Related Papers
Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
|Neurotoxicity Research|2017|36
Matrix metalloproteinases and atherosclerosis
|Postępy Higieny i Medycyny Doświadczalnej|2011|34
Effects of systemic administration of kynurenic acid and glycine on renal haemodynamics and excretion in normotensive and spontaneously hypertensive rats
|European Journal of Pharmacology|2014|26
Kynurenic acid selectively reduces heart rate in spontaneously hypertensive rats
|Naunyn-Schmiedeberg s Archives of Pharmacology|2019|18
Anticoagulant-related nephropathy: Focus on novel agents. A review
|Advances in Clinical and Experimental Medicine|2022|16